98 related articles for article (PubMed ID: 1495677)
1. The stability of 99Tcm directly labelled to an Fab' antibody via stannous ion and mercaptoethanol reduction.
Mardirossian G; Wu C; Rusckowski M; Hnatowich DJ
Nucl Med Commun; 1992 Jul; 13(7):503-12. PubMed ID: 1495677
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of the FO23C5 anti-CEA antibody fragment labelled with 99Tcm and 111In: a comparison in patients.
Hnatowich DJ; Mardirossian G; Rusckowski M; Roy S; Bushe H; Griffin TW; Brill AB
Nucl Med Commun; 1993 Jan; 14(1):52-63. PubMed ID: 8423936
[TBL] [Abstract][Full Text] [Related]
3. In vivo stability and metabolism of 99Tcm-labelled anti-CD4 monoclonal antibodies and Fab' fragments.
Kinne RW; Schemer K; Behr T; Sharkey RM; Palombokinne E; Emmrich F; Goldenberg DM; Wolf F; Becker W
Nucl Med Commun; 1999 Jan; 20(1):67-75. PubMed ID: 9949415
[TBL] [Abstract][Full Text] [Related]
4. Radiochemical and radioimmunological data of 99Tcm-anti-CEA labelled by two diverse methods.
Varvarigou AD; Archimandritis SC; Sekeri-Pataryas K; Sourlingas TG; Sivolapenko G; Paschali E
Nucl Med Commun; 1996 Jan; 17(1):80-8. PubMed ID: 8692479
[TBL] [Abstract][Full Text] [Related]
5. Structural modifications of monoclonal antibodies following direct versus indirect labelling with 99Tcm: does fragmentation really occur?
Behr T; Becker W; Hannappel E; Wolf F
Nucl Med Commun; 1994 Nov; 15(11):865-70. PubMed ID: 7870392
[TBL] [Abstract][Full Text] [Related]
6. Technetium-99m labelling of the anti-tumour antibody PR1A3 by photoactivation.
Stalteri MA; Mather SJ
Eur J Nucl Med; 1996 Feb; 23(2):178-87. PubMed ID: 8925853
[TBL] [Abstract][Full Text] [Related]
7. Human polyclonal immunoglobulin labelled with technetium-99m via NHS-MAG3: a comparison of radiochemical behavior and biological efficacy with other labelling methods.
Gano L; Patrício L; Marques E; Cantinho G; Pena H; Martins T; Hnatowich DJ
Nucl Med Biol; 1998 May; 25(4):395-403. PubMed ID: 9639302
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of reduction-mediated labelling of antibodies with technetium-99m.
Zhang ZM; Ballinger JR; Sheldon K; Boxen I
Int J Rad Appl Instrum B; 1992 Aug; 19(6):607-9. PubMed ID: 1522015
[TBL] [Abstract][Full Text] [Related]
9. Technetium-99m labelling of the IOR CEA 1 monoclonal antibody: evaluation of different methods.
Gano L; Fernandes C; Cantinho G; Santos AI; Pena H; Vieira R; Salgado L; Patrício L
Nuklearmedizin; 1997 Sep; 36(6):205-12. PubMed ID: 9380538
[TBL] [Abstract][Full Text] [Related]
10. Investigations of directly labeling antibodies with rhenium-188.
Winnard P; Virzi E; Fogarasi M; Rusckowski M; Hnatowich DJ
Q J Nucl Med; 1996 Jun; 40(2):151-60. PubMed ID: 8909100
[TBL] [Abstract][Full Text] [Related]
11. Technetium-99m labeled monoclonal antibodies: evaluation of reducing agents.
Thakur ML; DeFulvio J; Richard MD; Park CH
Int J Rad Appl Instrum B; 1991; 18(2):227-33. PubMed ID: 2026499
[TBL] [Abstract][Full Text] [Related]
12. Targeting of liver metastases of colorectal cancer with IgG, F(ab')2, and Fab' anti-carcinoembryonic antigen antibodies labeled with 99mTc: the role of metabolism and kinetics.
Behr T; Becker W; Hannappel E; Goldenberg DM; Wolf F
Cancer Res; 1995 Dec; 55(23 Suppl):5777s-5785s. PubMed ID: 7493346
[TBL] [Abstract][Full Text] [Related]
13. The binding parameters of radiolabelled monoclonal F (ab')2 and Fab' fragments relative to immunoglobulin G in reactions with surface-bound antigens.
Fjeld JG; Michaelsen TE; Nustad K
Eur J Nucl Med; 1992; 19(6):402-8. PubMed ID: 1618231
[TBL] [Abstract][Full Text] [Related]
14. Biodistribution in rats of 99Tcm-labelled human serum albumin.
Kristensen K
Nucl Med Commun; 1986 Aug; 7(8):617-24. PubMed ID: 3022217
[TBL] [Abstract][Full Text] [Related]
15. 99Tcm-labelled anti-CEA monoclonal antibody for tumour immunoscintigraphy: first clinical results.
Baum RP; Hertel A; Lorenz M; Schwarz A; Encke A; Hör G
Nucl Med Commun; 1989 May; 10(5):345-52. PubMed ID: 2662074
[TBL] [Abstract][Full Text] [Related]
16. Different chelators and different peptides together influence the in vitro and mouse in vivo properties of 99Tcm.
Qu T; Wang Y; Zhu Z; Rusckowski M; Hnatowich DJ
Nucl Med Commun; 2001 Feb; 22(2):203-15. PubMed ID: 11258408
[TBL] [Abstract][Full Text] [Related]
17. Radiolabeling of an anti-carcinoembryonic antigen antibody Fab' fragment (CEA-Scan) with the positron-emitting radionuclide Tc-94m.
Griffiths GL; Goldenberg DM; Roesch F; Hansen HJ
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3001s-3003s. PubMed ID: 10541334
[TBL] [Abstract][Full Text] [Related]
18. Can a cysteine challenge assay predict the in vivo behavior of 99mTc-labeled antibodies?
Hnatowich DJ; Virzi F; Fogarasi M; Rusckowski M; Winnard P
Nucl Med Biol; 1994 Nov; 21(8):1035-44. PubMed ID: 9234361
[TBL] [Abstract][Full Text] [Related]
19. A novel method for labelling human immunoglobulin-G with 99Tcm suitable for inflammation scintigraphy.
Mishra P; Singh AK; Chauhan M; Bhatnagar A; Kashyap R; Chauhan UP
Nucl Med Commun; 1994 Sep; 15(9):723-9. PubMed ID: 7816386
[TBL] [Abstract][Full Text] [Related]
20. Tumour detection and localization using 99Tcm-labelled OV-TL 3 Fab' in patients suspected of ovarian cancer.
Tibben JG; Massuger LF; Claessens RA; Schijf CP; Pak KY; Strijk SP; Kenemans P; Corstens FH
Nucl Med Commun; 1992 Dec; 13(12):885-93. PubMed ID: 1465272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
